Autolymphocyte therapy in the treatment of metastatic renal cell carcinoma.
Autolymphocyte therapy is outpatient adoptive immunotherapy based on the infusion of ex vivo activated memory T cells. Autolymphocyte therapy has been used to treat more than 500 patients with renal cell carcinoma and the mechanism of action as well as the clinical outcome of data are reviewed.
Sawczuk
I S
IS
Department of Urology, College of Physicians and Surgeons, Columbia University, New York, New York.
D002292:Carcinoma, Renal Cell / Q000401:mortality / Q000556:secondary* / Q000628:therapy*; D005260:Female; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007680:Kidney Neoplasms / Q000401:mortality / Q000628:therapy*; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D015996:Survival Rate; D013601:T-Lymphocytes / Q000276:immunology*